Inhibition of retinal neovascularization by soluble EphA2 receptor.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Experimental Eye Research

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EXER.2005.09.004PMID 16359662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

  2005cited by this paper
• Impaired tumor microenvironment in EphA2‐deficient mice inhibits tumor angiogenesis and metastatic progression

  2005cited by this paper
• EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation

  2004cited by this paper
• Inhibition of tumor growth and angiogenesis by soluble EphB4.

  2004cited by this paper
• Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.

  2004cited by this paper
• Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling

  2004cited by this paper
• Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.

  2004cited by this paper
• Role of ephrin B2 in human retinal endothelial cell proliferation and migration.

  2003cited by this paper
• Pharmacologic therapy for diabetic retinopathy

  2003cited by this paper
• Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity.

  2003cited by this paper
• Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis.

  2003cited by this paper
• Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

  2003cited by this paper
• Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

  2002cited by this paper
• Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis

  2002cited by this paper
• Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

  2002cited by this paper
• Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

  2001cited by this paper
• The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

  2001cited by this paper
• Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.

  2001cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

  2000cited by this paper
• Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase*

  2000cited by this paper
• The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

  2000cited by this paper
• Eph receptors and ephrins: effectors of morphogenesis.

  1999cited by this paper
• Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

  1999cited by this paper
• Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

  1999cited by this paper
• Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.

  1999cited by this paper
• Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

  1999cited by this paper
• The ephrins and Eph receptors in neural development.

  1998cited by this paper
• Ocular neovascularization: an epidemiologic review.

  1998cited by this paper
• VEGF localisation in diabetic retinopathy

  1998cited by this paper
• Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

  1998cited by this paper
• Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina.

  1998cited by this paper
• Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

  1997cited by this paper
• p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells

  1997cited by this paper
• Ephrins and their receptors: a repulsive topic?

  1997cited by this paper
• Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina.

  1997cited by this paper
• ELK and LERK-2 in developing kidney and microvascular endothelial assembly.

  1996cited by this paper
• Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis.

  1996cited by this paper
• Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.

  1996cited by this paper
• The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats.

  1995cited by this paper
• Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

  1995cited by this paper
• Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.

  1995cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis.

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• The expression of the receptor-protein tyrosine kinase gene, eck, is highly restricted during early mouse development.

  1994cited by this paper
• A new technique for visualization of the human retinal vasculature.

  1992cited by this paper
• Visualization of a developing vasculature.

  1987cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies

  2024cites this paper
• Transcription Factor EGR1 Facilitates Neovascularization in Mice with Retinopathy of Prematurity by Regulating the miR-182-5p/EFNA5 Axis

  2023cites this paper
• Interactions between ligand-bound EGFR and VEGFR2.

  2021cites this paper
• Host deficiency in ephrin-A 1 inhibits breast cancer metastasis [ version 2 ; peer review : 3 approved ]

  2021cites this paper
• Eph Receptors and Ephrins in Retinal Diseases

  2021cites this paper
• Host deficiency in ephrin-A1 inhibits breast cancer metastasis

  2020cites this paper
• Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling

  2020cites this paper
• Ephrin-A5 Is Involved in Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy

  2020cites this paper
• Effect of acute exposure of saxitoxin on development of zebrafish embryos (Danio rerio).

  2020cites this paper
• Host deficiency in ephrin-A1 inhibits breast cancer metastasis.

  2020cites this paper
• Approaches to Manipulate Ephrin-A:EphA Forward Signaling Pathway

  2020cites this paper
• Nova2 alternative splicing regulation of the netrin receptor Unc5b during angiogenesis

  2018cites this paper
• Expression of transient receptor potential canonical 1 ( TRPC 1 ) in tongue squamous cell carcinoma and correlations with clinicopathological features and outcomes

  2017cites this paper
• Deciphering the role of hydrophobic and hydrophilic bile acids in angiogenesis using in vitro and in vivo model systems.

  2017cites this paper
• A Critical Analysis of the Available In Vitro and Ex Vivo Methods to Study Retinal Angiogenesis

  2017cites this paper
• Axon Guidance Factors in Developmental and Pathological Angiogenesis

  2015cites this paper
• BIBF1120 (Vargatef) Inhibits Preretinal Neovascularization and Enhances Normal Vascularization in a Model of Vasoproliferative Retinopathy.

  2015cites this paper
• EPH receptor/ephrin system: in the quest for novel anti‐angiogenic therapies: Commentary on Hassan‐Mohamed et al., Br J Pharmacol 171: 5195–5208

  2015cites this paper
• A Dysregulated MicroRNA-26a/EphA2 Axis Impairs Endothelial Progenitor Cell Function via the p38 MAPK/VEGF Pathway

  2015cites this paper
• Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

  2014cites this paper
• Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics

  2014cites this paper
• Elevated Slit 2 Activity Impairs VEGF-induced Angiogenesis and Tumor Neovascularization in EphA 2-deficient Endothelium

  2014cites this paper
• Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins

  2014cites this paper
• VEGF Increases Paracellular Permeability in Brain Endothelial Cells via Upregulation of EphA2

  2014cites this paper
• Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium

  2014cites this paper
• Roles of EphA2 in Development and Disease

  2013cites this paper
• Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis.

  2013cites this paper
• Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.

  2013influential citation
• Gene Expression Changes under Cyclic Mechanical Stretching in Rat Retinal Glial (Müller) Cells

  2013cites this paper
• Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody

  2013cites this paper
• Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.

  2012cites this paper
• Eph/Ephrin signaling in injury and inflammation.

  2012cites this paper
• Eph family receptors as therapeutic targets

  2012cites this paper
• EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats.

  2012cites this paper
• Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.

  2012cites this paper
• Ephrin-A1 induces cell retraction to exert three- dimensional traction stress on the substrate via a PI3K- dependent pathway

  2012cites this paper
• INTEGRATION OF HSP90 INHIBITION IN COMBINATIONAL IMMUNOTHERAPIES TARGETING RECEPTOR TYROSINE KINASE EPHA2

  2012cites this paper
• Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway.

  2012cites this paper
• Ephs and ephrins in cancer: ephrin-A1 signalling.

  2012cites this paper
• Importance of Anti‐angiogenic Factors in the Regulation of Skeletal Muscle Angiogenesis

  2011cites this paper
• A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors

  2011cites this paper
• Therapeutic interference with EphrinB2 signalling inhibits oxygen‐induced angioproliferative retinopathy

  2011cites this paper
• Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis.

  2010cites this paper
• Cooperative Signaling between Slit2 and Ephrin-A1 Regulates a Balance between Angiogenesis and Angiostasis

  2010cites this paper
• The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

  2010cites this paper
• Vascular development in the primate macula : the role of guidance and anti-angiogenic factors

  2010cites this paper
• Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen‐induced retinopathy

  2010cites this paper
• Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling

  2010cites this paper
• EPH-EPHRIN in human gastrointestinal cancers.

  2010cites this paper
• Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

  2009cites this paper
• The neurovascular link in health and disease: an update.

  2009cites this paper
• EphA2 as a promoter of melanoma tumorigenicity

  2009cites this paper
• Host Deficiency in Vav2/3 Guanine Nucleotide Exchange Factors Impairs Tumor Growth, Survival, and Angiogenesis In vivo

  2009cites this paper
• EphA2: A Novel Target in Renal Cell Carcinoma

  2009cites this paper
• DEVELOPING COMBINATIONAL IMMUNOTHERAPIES TARGETING TUMOR RECEPTOR TYROSINE KINASES

  2009cites this paper
• Evolving strategies in manipulating VEGF/VEGFR signaling for the promotion of angiogenesis in ischemic muscle.

  2009cites this paper
• EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.

  2009cites this paper
• Mediators of ocular angiogenesis

  2009cites this paper
• Efficacy and safety of green laser photocoagulation for threshold retinopathy of prematurity.

  2008cites this paper
• Angiogenic Factors and Inhibitors

  2008cites this paper
• EPH RECEPTOR TYROSINE KINASES: MODULATORS OF ANGIOGENESIS

  2008cites this paper
• Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome.

  2008cites this paper
• The role of PI3K in Ephrin-A1 induced cell retraction

  2008cites this paper
• Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors*

  2008cites this paper
• Eph-ephrin bidirectional signaling in physiology and disease.

  2008cites this paper
• The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting

  2008influential citation
• Rodent Models of Oxygen-Induced Retinopathy

  2008cites this paper
• Eph Receptors and Ephrins: Role in Vascular Development and Tumor Angiogenesis

  2008cites this paper
• Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors

  2007cites this paper
• Vegf or EphA2 antisense polyamide-nucleic acids; vascular localization and suppression of retinal neovascularization.

  2007cites this paper
• Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice

  2007cites this paper
• JUN siRNA regulates matrix metalloproteinase-2 expression, microvascular endothelial growth and retinal neovascularisation

  2006cites this paper
• Regulation of the actin cytoskeleton by ephrin-B signalling

  2006cites this paper
• Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

  2006cites this paper